We're updating our draft quality standard for ovarian cancer, which is open for consultation until 18 Sept⬇️ nice.org.uk/guidance/indev… It includes new and updated statements to improve services in different priority areas of ovarian cancer identification, management and care.

What a fantastic weekend @manchesterpride. A huge thanks to all of our colleagues from across the School and The Christie NHS trust for all of your incredible support. We hope you enjoyed it as much as we did!

The EMA has approved Enfortumab Vedotin and pembrolizumab for 1st line urothelial cancer. It supersedes 1st platinum based therapy as the new standard of care in Europe. astellas.com/en/news/29371?…

NICE has recommended a new combination treatment for bowel cancer, with over a thousand people set to benefit. Find out more about trifluridine–tipiracil with bevacizumab⬇️ nice.org.uk/guidance/indev… #NICENews #BowelCancer

New treatment option for #gastriccancer recommended, with more than a thousand people set to benefit from pembrolizumab with chemotherapy. Find out more⤵️ nice.org.uk/guidance/ta997… #NICENews

Did you know, 79% of our recommendations on cancer drugs are positive? Find out more ⤵ nice.org.uk/about/what-we-… #NICE25

Thirty-six projects will share £32.4m from the first round of our new interdisciplinary scheme. We're also launching the second round of funding with a further £32.5 million available. More on the projects announced today: ukri.org/news/first-pro…

More details on round two of the funding: ukri.org/opportunity/uk… And our video playlist on what makes a good application: youtube.com/playlist?list=…

"So children are very unlucky, they just happen to have the mutations which will cause proliferation" Episode 5 #GPsTalkCancer covers childhood cancer, with specialist guest Dr Guy Makin. Listen now wherever you get your podcasts. 🎧bit.ly/3xBfrZl #childhoodcancer

September issue of Cancer Nursing Practice out now. In this issue, big focus on clinical nurse specialists, as well as articles on genomics, Lynch Syndrome and frailty. journals.rcni.com/toc/cnp/23/5

£12 million funding awarded to advance innovative cancer projects ukri.org/news/12-millio…

First projects from UKRI’s new interdisciplinary scheme announced ukri.org/news/first-pro…

UK celebrates £2 billion milestone in Horizon Europe guarantee funding ukri.org/news/uk-celebr…

Pleased to share our review published in Trends in Molecular Medicine on cell-free and extrachromosomal DNA profiling of small cell lung cancer 👉 tinyurl.com/4x572nxf Based on my MSc Precision Medicine research project supervised by Dr Florent Mouliere at CRUK National Biomarker Centre CRUK Manchester Institute Division of Cancer Sciences

Anti-inflammatory drug could reduce future heart attack risk shar.es/agcLwX

Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study christie.openrepository.com/handle/10541/6…